The first vancomycin-intermediate Staphylococcus aureus strains isolated from patients in Thailand

Journal of Clinical Microbiology

Volumn 47, Issue 7, 2009, Pages 2311-2316

  Lulitanond, Aroonlug ^a   Engchanil, Chulapan ^a   Chaimanee, Prajuab ^a   Vorachit, Malai ^b   Ito, Teruyo ^c   Hiramatsu, Keiichi ^c  

^a KHON KAEN UNIVERSITY   (Thailand)

^b MAHIDOL UNIVERSITY   (Thailand)

^c JUNTENDO UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CEFAZOLIN; ERYTHROMYCIN; GENTAMICIN; OFLOXACIN; OXACILLIN; TEICOPLANIN; TETRACYCLINE; VANCOMYCIN;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL STRAIN; BACTERIUM ISOLATION; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PRIORITY JOURNAL; SCREENING TEST; STAPHYLOCOCCUS AUREUS; SYSTEMATIC REVIEW; THAILAND; VANCOMYCIN INTERMEDIATE STAPHYLOCOCCUS AUREUS; VANCOMYCIN RESISTANT STAPHYLOCOCCUS AUREUS;

ADULT; AGED; AGED, 80 AND OVER; ANTI-BACTERIAL AGENTS; CHILD; CHILD, PRESCHOOL; COLONY COUNT, MICROBIAL; DNA, BACTERIAL; ELECTROPHORESIS, GEL, PULSED-FIELD; FEMALE; GENOTYPE; HUMANS; INFANT; MALE; METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS; MICROBIAL SENSITIVITY TESTS; MICROBIAL VIABILITY; MIDDLE AGED; STAPHYLOCOCCAL INFECTIONS; THAILAND; VANCOMYCIN; VANCOMYCIN RESISTANCE; YOUNG ADULT;

METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS AUREUS;

EID: 67650072498     PISSN: 00951137     EISSN: None     Source Type: Journal    
DOI: 10.1128/JCM.01749-08     Document Type: Article

References (36)

1. Appelbaum, P. C. 2006. MRSA - the tip of the iceberg. Clin. Microbiol. Infect. 12(Suppl. 2):3-10.
2. Beam, J. W., and B. Buckley. 2006. Community-acquired methicillin-resistant Staphylococcus aureus: prevalence and risk factors. J. Athl. Train. 41: 337-340.
3. Brummett, R. E. 1981. Effects of antibiotic-diuretic interactions in the guinea pig model of ototoxicity. Rev. Infect. Dis. 3(Suppl.):S216- S223.
4. Charles, P. G. P., P. B. Ward, D. P. R. Johnson, B. P. Howden, and M. L. Grayson. 2004. Clinical features associated with bacteremia due to heterogeneous vancomycin-intermediate Staphylococcus aureus. Clin. Infect. Dis. 38:448-451.
5. Clinical and Laboratory Standards Institute. 2006. Performance standards for antimicrobial susceptibility testing; 16th informational supplement, M100-S16. CLSI, Wayne, PA.
6. Enright, M. C., N. P. Day, C. E. Davies, S. J. Peacock, and B. G. Spratt. 2000. Multilocus sequence typing for characterization of methicillin-resistant and methicillin-susceptible clones of Staphylococcus aureus. J. Clin. Microbiol. 38:1008-1015.
7. Farber, B. F., and R. C. Moellering, Jr. 1983. Retrospective study of the toxicity of preparations of vancomycin from 1974 to 1981. Antimicrob. Agents Chemother. 23:138-141.
8. Fitzgibbon, M. M., A. S. Rossney, and B. O'Connell. 2007. Investigation of reduced susceptibility to glycopeptides among methicillin-resistant Staphylococcus aureus isolates from patients in Ireland and evaluation of agar screening methods for detection of heterogeneously glycopeptide-intermediate S. aureus. J. Clin. Microbiol. 45:3263-3269.
9. Fridkin, S. K., J. Hageman, L. K. McDougal, J. Mohammed, W. R. Jarwis, T. M. Perl, and F. C. Tenover. 2003. Epidemiological and microbiological characterization of infections caused by Staphylococcus aureus with reduced susceptibility to vancomycin, United States, 1997-2001. Clin. Infect. Dis. 36:429-439.
10. Gemmel, C. G. 2004. Glycopeptide resistance in Staphylococcus aureus: is it a real threat? J. Infect. Chemother. 10:69-75.
11. Griffith, R. S. 1981. Introduction to vancomycin. Rev. Infect. Dis. 3(Suppl.): S200-S204.
12. Hicks, N. R., E. P. Moore, and E. W. Williams. 1991. Carriage and community treatment of methicillin-resistant Staphylococcus aureus: what happens to colonized patients after discharge? J. Hosp. Infect. 19:17-24.
13. Hiramatsu, K., N. Aritaka, H. Hanaki, S. Kawasaki, Y. Hosoda, S. Hori, Y. Fukuchi, and I. Kobayashi. 1997. Dissemination in Japanese hospitals of strains of Staphylococcus aureus heterogeneously resistant to vancomycin. Lancet 350:1670-1673.
14. Hiramatsu, K., H. Hanaki, T. Ino, K. Yabuta, T. Oguri, and F. C. Tenover. 1997. Methicillin-resistant Staphylococcus aureus clinical strain with reduced vancomycin susceptibility. J. Antimicrob. Chemother. 40:135-136.
15. Hiramatsu, K. 2001. Vancomycin-resistant Staphylococcus aureus: a new model of antibiotic resistance. Lancet Infect. Dis. 1:147-155.
16. Hollis, R. J., J. L. Barr, B. N. Doebbeling, M. A. Pfaller, and R. P. Wenzel. 1995. Familial carriage of methicillin-resistant Staphylococcus aureus and subsequent infection in a premature neonate. Clin. Infect. Dis. 21:328-332.
17. Howe, R. A., A. Monk, M. Wootton, T. R. Walsh, and M. C. Enright. 2004. Vancomycin susceptibility within methicillin-resistant Staphylococcus aureus lineages. Emerg. Infect. Dis. 10:855-857.
18. Howe, R. A., M. Wootton, T. R. Walsh, P. M. Bennett, and A. P. Macgowan. 2000. Heterogeneous resistance to vancomycin in Staphylococcus aureus. J. Antimicrob. Chemother. 45:130-131.
19. Huang, S. S., and R. Platt. 2003. Risk of methicillin-resistant Staphylococcus aureus infection after previous infection or colonization. Clin. Infect. Dis. 36:281-285.
20. Jevons, M. P. 1961. 'Celbenin'-resistant staphylococci. Br. Med. J. 1:124-125.
21. Kaccia, M., and L. C. McDonald. 2004. Vancomycin-resistant Staphylococcus aureus - New York. MMWR Morb. Mortal. Wkly. Rep. 53:322-323.
22. Kondo, Y., T. Ito, X. X. Ma, S. Watanabe, B. N. Kreiswirth, J. Etienne, and K. Hiramatsu. 2007. Combination of multiplex PCRs for staphylococcal cassette chromosome mec type assignment: rapid identification system for mec, ccr, and major differences in junkyard regions. Antimicrob. Agents Chemother. 51:264-274.
23. Liu, C., and H. F. Chambers. 2003. Staphylococcus aureus with heterogeneous resistance to vancomycin: epidemiology, clinical significance, and critical assessment of diagnostic methods. Antimicrob. Agents Chemother. 47: 3040-3045.
24. Lulitanond, A., A. Chanawong, P. Sribenjalux, W. Kaewkes, N. Charoensri, D. Leumsai, and P. Monpou. 2005. Occurrence of methicillin-resistant Staphylococcus aureus with reduced susceptibility to vancomycin in Srinagarind Hospital. J. Infect. Dis. Antimicrob. Agents 22:9-14.
25. Marchese, A., G. Balistreri, E. Tonoli, E. A. Debbia, and G. C. Schito. 2000. Heterogeneous vancomycin resistance in methicillin-resistant Staphylococcus aureus strains isolated in a large Italian hospital. J. Clin. Microbiol. 38:866-869.
26. Miller, D., V. Urdaneta, and A. Weltman. 2002. Vancomycin-resistant Staphylococcus aureus - Pennsylvania. MMWR Morb. Mortal. Wkly. Rep. 51:902.
27. Saha, B., A. K. Singh, A. Ghosh, and M. Bal. 2008. Identification and characterization of a vancomycin-resistant Staphylococcus aureus isolated from Kolkata (South Asia). J. Med. Microbiol. 57:72-79.
28. Schwaber, M. J., S. B. Wright, Y. Carmeli, L. Venkataraman, P. C. DeGirolami, A. Gramatikova, T. M. Perl, G. Sakoulas, and H. S. Gold. 2003. Clinical implications of varying degrees of vancomycin susceptibility in methicillin-resistant Staphylococcus aureus bacteremia. Emerg. Infect. Dis. 9:657-664.
29. Shaw, B. E., T. Boswell, J. L. Byrne, C. Yates, and N. H. Russell. 2007. Clinical impact of MRSA in a stem cell transplant unit: analysis before, during and after an MRSA outbreak. Bone Marrow Transplant. 39:623-629.
30. Shopsin, B., B. Mathema, P. Alcabes, B. Said-Salim, G. Lina, A. Matsuka, J. Martinez, and B. N. Kreiswirth. 2003. Prevalence of agr specificity groups among Staphylococcus aureus strains colonizing children and their guardians. J. Clin. Microbiol. 41:456-459.
31. Tenover, F. C., R. D. Arbeit, R. V. Goering, P. A. Mickelsen, B. E. Murry, D. H. Persing, and B. Swaminathan. 1995. Interpreting chromosomal DNA restriction patterns produced by pulsed-field gel electrophoresis: criteria for bacterial strain typing. J. Clin. Microbiol. 33:2233-2239.
32. Trakulsomboon, S., S. Danchaivijitr, Y. Rongrungruang, C. Dhiraputra, W. Susaemgrat, T. Ito, and K. Hiramatsu. 2001. First report of methicillin-resistant Staphylococcus aureus with reduced susceptibility to vancomycin in Thailand. J. Clin. Microbiol. 39:591-595.
33. Voss, A., J. W. Mouton, E. P. van Elzakker, R. G. Hendrix, W. Goessens, J. A. Kluytmans, P. F. Krabbe, H. J. de Neeling, J. H. Sloos, N. Oztoprak, R. A. Howe, and T. R. Walsh. 2007. A multi-center blinded study on the efficiency of phenotypic screening methods to detect glycopeptide intermediately susceptible Staphylococcus aureus (GISA) and heterogeneous GISA (h-GISA). Ann. Clin. Microbiol. Antimicrob. 6:9-13.
34. Walsh, T. R., A. Bolmström, A. Qwärnström, P. Ho, M. Wootton, R. A. Howe, A. P. MacGowan, and D. Diekema. 2001. Evaluation of current methods for detection of staphylococci with reduced susceptibility to glycopeptides. J. Clin. Microbiol. 39:2439-2444.
35. Wong, S. S., P. L. Ho, P. C. Woo, and K. Y. Yuen. 1999. Bacteremia caused by staphylococci with inducible vancomycin heteroresistance. Clin. Infect. Dis. 29:760-767.
36. Wong, S. S., T. K. Ng, W. C. Yam, D. N. Tsang, P. C. Woo, S. K. Fung, and K. Y. Yuen. 2000. Bacteremia due to Staphylococcus aureus with reduced susceptibility to vancomycin. Diagn. Microbiol. Infect. Dis. 36:261-268.